Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSF1R | P07333 | 2/20 | 0.53 |
| ▸ | KIT | P10721 | 1/20 | 0.53 |
| ▸ | BRAF | P15056 | 10/20 | 0.53 |
| ▸ | KDR | P35968 | 7/20 | 0.53 |
| ▸ | LCK | P06239 | 5/20 | 0.53 |
| ▸ | INSR | P06213 | 4/20 | 0.53 |
| ▸ | LYN | P07948 | 4/20 | 0.53 |
| ▸ | SRC | P12931 | 4/20 | 0.53 |
| ▸ | HCK | P08631 | 3/20 | 0.53 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.53 |
| ▸ | TEK | Q02763 | 1/20 | 0.52 |
| ▸ | DDR2 | Q16832 | 1/20 | 0.51 |
| ▸ | RAF1 | P04049 | 1/20 | 0.50 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.50 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.50 |
| ▸ | PIKFYVE | Q9Y2I7 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4586222 | 0.89 | PIKFYVE (0.57) | CSF1RKITBRAFKDRLCK | |
| SCHEMBL4586545 | 0.87 | KDR (0.52) | CSF1RKITBRAFKDRLCK | |
| SCHEMBL4588535 | 0.86 | BRAF (0.57) | CSF1RKITBRAFKDRLCK | |
| SCHEMBL4587484 | 0.85 | KDR (0.53) | CSF1RKITBRAFKDRLCK | |
| SCHEMBL4697842 | 0.84 | BRAF (0.64) | CSF1RKITBRAFKDRTEK | |
| SCHEMBL2466430 | 0.84 | LCK (0.71) | KDRLCKINSRLYNSRC | |
| SCHEMBL1828497 | 0.82 | BRAF (0.64) | CSF1RKITBRAFKDRLCK | |
| SCHEMBL4588492 | 0.82 | ABL1 (0.58) | CSF1RKITBRAFKDRLCK | |
| SCHEMBL4587914 | 0.82 | KDR (0.50) | CSF1RKITBRAFKDRLCK | |
| SCHEMBL3227999 | 0.81 | KDR (0.71) | CSF1RKITBRAFKDRLCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080188483-A1 | Compounds and Compositions as Protein Kinase Inhibitors | IRM LLC (BM) | 2008-08-07 | — | — | US | claimed |
| US-20080188483-A1 | Compounds and Compositions as Protein Kinase Inhibitors | IRM LLC (BM) | 2008-08-07 | — | — | US | disclosed |
| US-20080188483-A1 | Compounds and Compositions as Protein Kinase Inhibitors | IRM LLC (BM) | 2008-08-07 | — | — | US | disclosed |
| US-20080188483-A1 | Compounds and Compositions as Protein Kinase Inhibitors | IRM LLC (BM) | 2008-08-07 | — | — | US | disclosed |
| EP-1858521-A2 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHBITORS | IRM, LLC (BM) | 2007-11-28 | — | — | EP | disclosed |
| WO-2006101783-A2 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | IRM LLC (BM) | 2006-09-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080188483-A1 | Compounds and Compositions as Protein Kinase Inhibitors | SRC, SGK2, PTK2B | CSF1R 788/4885KIT 600/4885BRAF 82/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.